Renovo News
-
21st June 2007Renovo Group plc (LSE: RNVO), the biopharmaceutical company developing drugs for the prevention and reduction of scarring at multiple body sites, announces that Professor Mark Ferguson, the Compa...read more
-
20th June 2007RENOVO GROUP PLC RENOVO AND SHIRE ENTER LICENSING AGREEMENT TO DEVELOP AND COMMERCIALISE JUVISTA®...read more
-
17th April 2007RENOVO ANNOUNCES POSITIVE PHASE II EFFICACY TRIAL RESULTS FOR PREVASCAR...read more
-
17th January 2007Click here for Renovo's latest Annual Report in pdf format....read more
-
4th December 2006RENOVO SELECTED BY THE WORLD ECONOMIC FORUM AS A TECHNOLOGY PIONEER FOR 2007...read more
-
24th October 2006FURTHER POSITIVE PHASE II CLINICAL TRIAL RESULTS FOR JUVISTA AND PIPELINE UPDATE...read more
-
28th September 2006RENOVO ANNOUNCES HIGHLY POSITIVE PHASE II TRIAL RESULTS FOR JUVISTA...read more